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ABSTRAK 
Pneumonia dalam kalangan pesakit buah pinggang kronik: Kajian keatas ciri-ciri dan hasil        
klinikal 
 
Latarbelakang: Pesakit buah pinggang kronik dikenalpasti sebagai satu kumpulan pesakit yang 
mudah mendapat pelbagai jangkitan dan mempunyai prognosis yang lemah. Namun begitu, tidak 
banyak kajian yang dijalankan ke atas kumpulan ini untuk menentukan ciri-ciri klinikal mereka 
dan memastikan hasil atau keputusan dari pneumonia. 
 
Kaedah: Semua pesakit yang dimasukkan ke Hospital Universiti Sains Malaysia untuk penyakit 
komuniti pneumonia bermula dari Januari 2014 hingga  Mei 2016 disaring kelayakannya untuk 
kajian ini. Nota kes subjek yang layak kemudiannya diekstrak daripada unit rekod dan dibuat 
semakan. 
 
Keputusan: Sebanyak  398 rekod perubatan subjek diambil dari unit rekod dan dibahagikan 
pada nisbah 1:1 antara subjek pesakit buah pinggang kronik dan tidak kronik. Kami mendapati 
pesakit buah pinggang kronik adalah lebih tua (min umur 64 vs 56, dengan nilai P <0.05), 
mempunyai kadar morbiditi sama yang lebih tinggi, lebih ramai perokok dan tidak ramai 
divaksin. Mereka juga menunjukkan lebih berada dalam keadaan kejutan septisimia dan 
mempunyai status mental terubah (46%vs 23% P <0.05 dan 56% vs 26%, P<0.05), radiograf 
dada yang lebih teruk (54% vs 29%, P<0.05) dan skor PSI kumpulan  yang lebih tinggi (52% vs 
20%,P<0.05) berbanding pesakit lain yang bukan pesakit buah pinggang kronik. Kajian juga 
mendapati pesakit buah pinggang kronik mempunyai keputusan yang tidak memuaskan dengan 
x 
 
kadar mortaliti lebih tinggi (35% vs 12.7%, P<0.05), kadar kemasukan ke HDW/ICU lebih tinggi 
(50.2%vs 22%,P<0.05), median tempoh tinggal di hospital lebih lama (9 hari vs 6 hari,P<0.05) 
dan lebih ramai subjek  yang memerlukan ventilasi mekanikal (37% vs 19.6%, P<0.005) .  
 
Kesimpulan: Secara keseluruhannya kami menyimpulkan bahawa pesakit buah pinggang kronik 
mempunyai factor risiko yang tinggi yang boleh menyumbang kepada prognosis yang lemah.  
Namun begitu, kami mendapati kadar kematian untuk subjek kami melibatkan subjek yang 
mendapat komplikasi  terutamanya mendapat jangkitan nosocomial.kami berpendpat dengan 
mengurangkan kadar jangkitan nosocomial maka kadar kematian dikalangan pesakit buah 
pinngang kronik yang mendapat jangkitan pneumonia  
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ABSTRACT 
 
Background: Chronic kidney disease (CKD) patient is recognized as group of patient 
prone for various infection with poorer prognosis. However, not many studies have been 
done for this group of patient to determine their clinical features and to ascertain their 
outcomes in pneumonia.  
 
Methods: All patients admitted for community acquired pneumonia from January 2014 
to May 2016 in Hospital Universiti Sains Malaysia, Kubang Kerian Kelantan were 
screened for the eligibility to enroll in this study. Eligible subjects case notes were then 
extracted from the record office and reviewed.   
 
Result: During the study period, a total of 398 subject’s medical records were extracted 
from the record office, and were divided to 1:1 ratio between CKD and Non CKD 
subjects. CKD patient was noted significantly older (Mean age 64 vs 56, with P value 
<0.05), having more co morbidity, more smoker and less vaccinated. They did present as 
more in septicaemia shock and altered mental status (46% vs 23% P <0.05 and 56% vs 
26%, P <0.05) with more severe chest radiograph (54% vs 29%, P <0.05) and more in 
high PSI score group (52% VS 20%, P <0.05) than were other patients without CKD. 
Patient with chronic kidney disease was also noted to have more unfavorable outcomes, 
higher mortality (35% vs 12.7%, P <0.05), higher HDW/ICU admission rate (50.2% vs 
22%, P <0.05), longer median length of stay (LOS) (9 days VS 6 days, P <0.05), and 
xii 
 
more subjects required mechanical ventilation (37% VS 19.6%, P <0.05) as compared to 
subjects without Chronic kidney disease.  
 
 
Conclusion: We concluded that in overall picture CKD patient did come with higher 
prevalence with risk factor that can contribute to poorer prognosis. However, we did 
found that mortality in our subjects merely involved subjects that develop complication 
especially a nosocomial infection. This fact auspiciously provides us with a guide to 
further reduced mortality in CKD subjects with community acquired pneumonia.   
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1. INTRODUCTION 
Chronic kidney disease (CKD) is fast emerging as a major public health problem (National 
Kidney Foundation 2002). Infection is common cause of morbidity and mortality in chronic 
kidney disease patient (Diego et al 2011). Although patients with CKD have an increased 
risk of bloodstream infection, urinary tract infection and pneumonia, little attention has been 
given to it and furthermore most of it is preventable (National kidney foundation 2002, James 
MT et al 2008, Naqvi SB and Collins AJ 2006). 
 When compared with the non-CKD population, the rates of pneumonia are 3 times greater in 
the CKD population and 5 times greater in the dialysis population (Naqvi SB and Collins AJ 
2006). Despite being high risk and recognized as a special group, little is known in regard to 
its clinical presentation and outcome especially in Malaysian population.  
Clinical presentation of the patient is of paramount importance to guide physician to initiate 
best line of treatment.  As described clearly by Diego et al (2011) a CKD patient present 
differently for pneumonia.  In this study Diego and his colleague pointed out that the 
majority of CKD population will come with severe pneumonia at presentation as compared 
to general population. It is not known however in this study if the patient have actually been 
presented earlier and treated with inappropriate treatment regime, i.e antimicrobial prior to 
admission. Thus it is of paramount importance to address this issue in regards to antibiotic 
usage and its limitation (due to impaired kidney function). As Malaysia have a different 
demographic background as compared to Diego et al study population, expanding knowledge 
regarding our own pneumonia pattern will definitely give an impact to current practice.  
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Diego et al also highlighted that prior pneumococcal vaccination did offer a protective factor 
for severe pneumonia especially in CKD population.  Earlier meta analysis done by Anke 
Huss et al however indicated that vaccination was not an answer to prevent pneumonia even 
in high risk group such as CKD patient (Anke Huss et al  2009). Again, this issue was never 
investigated with regard to CKD patient in our community. Thus it is not known if our CKD 
patient was vaccinated and if vaccination affect prevention of pneumonia or severe 
pneumonia. 
Streptoccoccus Pneumoniae was dominantly cultured in CKD patient as found out by Diego 
et al study. They also found out that there was no significant difference in CKD patient and 
non CKD patient with regards to etiology factor. This study did reveal however, that 
microbiology study was less performed in patient with CKD, a distinct clinical presentation 
was cited as the cause of this finding. With different presentation and clinical manifestation 
resulting with less favorable outcome (as portrayed by Diego et al), it is a compelling 
indication for further evaluation and research for this group of patient. 
1.1 Pneumonia overview 
1.1.1 Diagnosis of pneumonia 
 Pneumonia can be easily defined as infection of lung tissue.  Some would more 
specifically define it as infection of lung parenchyma. However, as other disease, 
pneumonia also has had its own diagnostic criteria or diagnostic definition. A diagnostic 
criterion is important especially for the enrollment to the pneumonia clinical study.  
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Various recognizable society gave out their own definition and diagnostic criteria. The core of it 
however, seems to be coherent to each other. BTS (British Thoracic Society) defined a diagnosis 
of pneumonia as presence of acute lower respiratory tract symptoms and signs and can be 
confirmed by a positive chest x ray finding (NICE Pneumonia 2014). 
 
A constellation of suggestive clinical features, and a demonstrable infiltrate by chest radiograph 
or any other radiological/imaging technique, with or without support by a positive 
microbiological cultures was suggested as diagnostic criteria for pneumonia by the Infectious 
Disease Society of America/ American Thoracic Society (IDSA/ATSC) Consensus guideline on 
management of community acquired pneumonia in adult (Mandel et al, 2007).  
 
IDSA/ATSC and BTS diagnostic criteria share common similarities in term of suggestive 
clinical features and support by radiological evidence in diagnosing pneumonia.  IDSA/ATSC 
however, adds on a positive microbiological culture as additional supporting evidence. 
 
Chest radiograph is an important supporting evidence of pneumonia diagnosis in both NICE 
2014 guideline as well as in IDSA/ATSC guideline. Typical chest radiograph finding in 
community acquired pneumonia range from lobar consolidation, interstitial infiltrate, and/or 
consolidation. However, evidence suggests that there is no significant difference in radiological 
finding between bacterial etiology versus non bacterial etiology in pneumonia patient (Marie TJ, 
1994). Furthermore, there is also potentially substantial interobserver variation between 
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radiologists as well as between emergency physician and radiologist as pointed out in several 
studies (Hopstaken et al 2004, Albaum et al 1996, Campbell et al 2005). Hence, a more accurate 
radiological investigation such as high resonance CT scan is needed to confirm the diagnosis in 
certain cases (Claessens et al 2015).  
 
In summary, a diagnosis of pneumonia can be made based on suggestive clinical symptoms and 
supported by a chest radiograph with typical pneumonia features and can be further reinforced by 
a positive microbiological culture.  A HRCT scan has proven more superior than chest 
radiograph to detect a pneumonia lesion (Claessens et al 2015).  
 
1.1.2 Incidence of pneumonia 
Worldwide estimation of pneumonia burden involved approximately 450 million people 
annually. In UK, incidence rate was estimated at around 6 cases per 1000 population age 18-39 
year old, and the figure increase to 75 cases per 1000 population in 75 year old population group 
(Hoare Z and Lim WS 2009).Chou CY et al found that estimated incidence of pneumonia among 
CKD patient was 65.6 per 1000 person-years, whereas Non CKD person the incidence was 28.4 
per 1000 person-years. 
 Chronic kidney disease group patient is known to have an increased risk of infection, with 
pneumonia being one of it. It was also postulated that this group of patient had poorer prognosis 
as compared to general population (Naqvi SB and Collins AJ 2006, Slinin Y, Foley RN  and 
Collins AJ 2006). 
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1.1.3 Clinical features of pneumonia 
Majority of previous studies concentrated more on management of pneumonia, rather than 
identifying more accurate symptoms and signs of pneumonia. NICE 2014 elaborated in detail 
with regard to clinical signs and symptoms of pneumonia. It defined pneumonia as an infection 
of lung tissue, diagnosed based on signs and symptoms of an acute lower respiratory tract 
infection. Cough is usually the main symptom, accompanied with at least one other symptom 
such as fever, sputum production, breathlessness, wheezing or chest discomfort or pain without 
any other explainable cause.  This list is not unfamiliar to our medical fraternity, consistent with 
the high frequency of pneumonia diagnosis. 
 
Unfortunately, systemic review of clinical symptoms such cough, and clinical sign such as fever, 
tachycardia and typical lung finding of crackles only offer a sensitivity of less than 50% even 
after using chest radiograph findings as standard investigation (Metlay JP and Fine MJ, 2003), 
making the diagnosis of pneumonia difficult. Daily clinical rounds however, usually lead by 
progressive clinical evidence, enabling other clinical possibility to be treated simultaneously or 
being considered as soon as new and contrary evidence is eminent. Various earlier studies 
explored further in regards to clinical features of community acquired pneumonia (CAP). Metlay 
and his friend, Fine had another review done earlier in 1997, reviewing various article associated 
with community acquired pneumonia to determine what clinical features and history can predict 
likelihood of CAP. In this article Matley and his colleague finally concluded that no constellation 
of historical and physical findings should be able to diagnose pneumonia accurately. However, 
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they did find in their review that a diagnosis of CAP is less likely in the absence of vital sign 
abnormality and lung physical findings such as crackles (Metlay et al, 1997).  Elderly patient 
require more careful evaluation as they may present differently and atypically. Various articles 
have suggested screening patient with probable pneumonia with pulse oximetry to detect 
hypoxaemia to be essential especially in people with atypical presentation (Fine MJ et al 1997, 
Mover WR et al 1995, Levin KP et al 2001)  
 
A set of clinical features has been used as severity parameters in the current standard practice. 
CURB 65 and Pneumonia Severity Index (PSI) is the two most popular calculators to determine 
the severity of pneumonia. Thus, all the clinical features listed in both list are important and 
significant clinical features of pneumonia. CURB 65 comprised of a Conscious level (C) – based 
on the assessment of mental state orientation towards place, person and time. U was designated 
for assessment of urea. A level more than 7.0 mmol/L would be considered as abnormal result. 
Another important parameter in this scoring system is respiratory rate. An abnormal result is 
defined with a respiratory rate of 30 and above. The B stands for abnormal blood pressure.  A 
systolic level of 90 and below and a diastolic level of 60mmHg and below is considered as 
abnormal. Lastly this scoring system also consider age factor as an important risk factor. 
 
Pneumonia Severity index (PSI) has been also been widely used by medical practitioners to 
grade the severity of pneumonia. PSI is a more comprehensive and detailed tool with 20 
variables. Among the clinical features listed in PSI is presence of altered mental status, low 
blood pressure, tachycardia, tachypnoea and abnormal body temperature. Aujesky considered all 
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these clinical features merely important features for prognostication rather than diagnosing 
(Aujesky D et al 2005).  
.  
1.1.4 Etiology of pneumonia 
IDSA/ATSC strongly advised for etiologic directed therapy in pneumonia. It is more 
fundamental especially in severe pneumonia. However, no similar strong recommendation has 
been made for patient with community acquired pneumonia treated as outpatient. This is because 
various evidence showed that culture and sensitivity test to determine etiology in this group of 
patient is rarely done. However, they  seems to respond well on current empirical antibiotic 
usage (Malcom C and marrie TJ 2003, Fine MJ et al 1997)  
 
Appropriate test is important in order to detect or to determine an appropriate etiology of 
pneumonia. Various studies have reviewed the effectiveness of selected clinical laboratory test 
for this job. IDSA/ATSC suggested that pre treatment blood culture and sensitivity would give a 
positive yield between 5-14%. This figure was based on its review on multiple articles (Mandell 
et al 2007). IDSA/ATSC also highlighted the importance of taking blood culture prior to 
initiation of antibiotic. It is known that blood culture and sensitivity yield is reduced to half with 
prior antibiotic therapy (Metersky ML et al 2004). Blood culture was assigned as optional in 
majority of CAP cases. IDSA/ATSC only emphasized the importance of this test in several 
selected cases such as severe pneumonia and patient with multiple risk factors for bacteremia. 
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Sputum culture is one of the common investigations done for CAP patient. However, it  has been 
highlighted as giving out a low yield by IDSA/ATSC consensus. It also known that high PSI 
does not contribute to high yield in sputum culture as blood culture does. The main setback for 
sputum culture is in producing satisfactory sample, as it is affected by transportation issues as 
well as quality of the entire sample processing step.   
 
Other culture commonly done for CAP patient is pleural fluid culture. Although has been tagged 
as a low yield by IDSA/ATSC; it has a significant impact on management decision for either 
antibiotic usage or indication of drainage.  
 
Antigen test is another test frequently performed in CAP patient. Of the various antigen tests 
available, the legionalle urinary antigen test offer good alternatives to culture tests, especially 
when culture sample is difficult to obtain or unable to give a good yield.  
 
Overall etiology of pneumonia is determined by various factors. According to Daniel and Anna, 
pre vaccine era bugs, streptococcus pneumonie remained the dominant organism in CAP patient. 
His prevalence however was significantly reduced from 95% in those era to current situation of 
10 -15% (Daniel and Anna 2014). The dominant organisms found in CAP patient would be S. 
Pneumonie, K. pneumonie,  mycoplasma and hemophilus influanzae. IDSA/ATSC highlighted 
slight differences in term of dominant organism in non ICU versus ICU patients. They found that 
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S. aureus organism was also common in patients treated in ICU. Etiologies of pneumonia in 
CKD patient versus non CKD remain the same with almost similar pattern in Diego et al study.  
 
1.1.5 Outcomes of pneumonia 
Mortality for inpatient CAP patient is about 10-12% (Daniel and Anna 2014, Fine MJ et al 
1997). Diego et al 2011 found that there is an increase in overall mortality in CKD patient. 
However he also found that there no significant difference in term of ICU admission and need 
for mechanical ventilation (Diego et al 2011) 
 
Health care associated pneumonia or HCAP is a different entity that postulated having different 
outcome and clinical entity. It is advisable that this group of patient to be differentiated with the 
current group of CAP (Kollef MH 2005). However, recent studies suggest that HCAP concept 
does not accurately identify resistant organisms and its high mortality not merely because of 
higher frequency of resistant organisms (Chalmers JD et al 2014, Gross AE et al 2014, and Yap 
V et al 2013). 
   
Outcome of pneumonia can be affected by various factors, various studies was done to address 
this issue. CURB 65 and PSI assessment as discussed earlier can be used for prediction of 
pneumonia severity as well as its prognosis and mortality prediction. 
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Beyond these two scoring systems, a retrospective analysis was done by Metersky ML with a 
database of more than 21000 patients. Seven factors were identified to be significantly associated 
with mortality prior to discharge. The seven factors were; a systolic blood pressure of less than 
90 mmHg, respiratory rate more than 30 breaths per minutes, presence of bacteriemia, arterial 
PH less than 7.35, blood urea more than 11 mmmol/L, arterial partial oxygen concentration less 
than 60mmHg or saturation of oxygen <90% and lastly the need for mechanical ventilation 
(Metersky ML et al 2012). Even though most of the factors have already been listed in CURB 65 
as well as in PSI scoring system, this study further emphasized important factors that can 
contribute to pneumonia severity as well as prognosis and outcome.    
 
Prognosis and outcomes also can be affected in the group of patient called ‘non responding’ 
patient. Menendez R quantified this group of pneumonia patients as those who were not 
responding to empirical antibiotic treatment within the first 72 hour. His study was able to 
identify 15.1% of their subjects as non responder. Those with liver disease, high pneumonia risk 
class, leucopenia, severe radiograph features such as multilobar, pleural effusion and cavitation 
were identified as independent risk factors for the non responder. Mortality can be as high as 
25% in the non responder group (Menendez R et al 2004) 
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1.2 Overview of Chronic Kidney Disease 
International society of nephrology via its KDIGO 2012 clinical practice guideline for evaluation 
and management of chronic kidney disease(CKD) defined CKD as abnormalities of kidney 
structure or function, present for more than 3 months duration with implication to health. They 
further explained that CKD criteria can be either presence of any marker of chronic kidney 
disease such as presence of significant albuminuria, urine sediment abnormalities, histological 
abnormalities, history of renal transplant, structural abnormalities noted by imaging modalities, 
electrolyte abnormalities caused by tubular disorder or presence of decreased glomerular 
filtration rate (GFR) of less than 60ml/min/1.73m2 (International Society Of Nephrology (ISN) 
2012) 
 
Definition of GFR of less than 60ml/min/1.73m2 was suggested by KDIGO guideline which  
represented less than half of normal value in normal adult man and women (International Society 
of Nephrology 2012). This estimated calculation was based on various hallmark studies as early 
as Rowe JW et al in early 1976 and further supported by latest study done by Rule AD et al and 
Poggio et al in year 2010 and 2009 respectively.  
 
Various evidences pointed out that a GFR less than 60ml/min/1.73m2 is associated with higher 
risk of complication when compared to subjects with GFR more than the above figure. Among 
the most popular was a Meta analysis done by Matshusita K et al 2010. This Metaanalysis 
showed an association of eGFR less than 60ml/min/1.73m2 with cardiovascular mortality, kidney 
failure and risk of CKD progression (Matshusita et al 2010).   
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KDIGO also suggested current routine laboratory testing to estimate GFR (eGFR) using serum 
creatinine as one of the marker was sensitive enough to detect GFR of 60ml.min/1.73m2.  They 
also postulated that at this level of GFR subjects are more prone to other complication such as 
drug toxicity, metabolic and endocrine complication (International Society of Nephrology 2012).  
 
KDIGO guidelines further classified CKD into a few categories. Chronic kidney disease is 
commonly divided into stages based on either eGFR or its albuminuria level. Staging based on 
estimated glomerular filtration rate are the most frequently used in clinical practice. Matsushita 
et al 2012 study found that both albuminuria level as well as estimated glomerular filtration rate 
was equivalent in estimating adverse implication to health.  
 
Stages of chronic kidney disease based on estimated glomerular filtration rate were divided into 
5 stages (Table 1.1). 1st stage or level known as G1 stage is defined as estimated glomerular 
filtration rate of more than 90ml/min/1.73m2 and is described as normal or high kidney function. 
Second stage is for estimated glomerular filtration rate between 60- 89ml/min/1.73m2, and is 
described as having mildly decreased renal function. Both stage were not considered to fulfill the 
chronic kidney disease definition unless they have other evidence of kidney damage. The chronic 
kidney disease stages continue with stage G3a whereby its estimated glomerular filtration rate 
ranged from 45 to 59ml/min/1.73m2. This stage is illustrated as having mildly to moderately 
impaired kidney function. G3b stage have an estimated glomerular filtration rate of 30 – 
44ml/min/1.73m2. This stage is further described as having moderate to severe kidney function 
13 
 
impairment.  Stage G4 with estimated glomerular filtration rate of 15 – 29ml/min/1.73m2, is 
categorized as having severely decreased renal function.  Lastly grade G5 with estimated 
filtration rate of 0 – 14ml/min/1.73m2. This group is classified as having renal failure.  
 
Chronic kidney disease based on degree of albuminuria was divided into three different stages 
(Table 1.2). They divided the category into 3 parts, 1st category A1has albuminuria excretion rate 
of less than 3mg/mmol. This category is described as having normal to mildly impaired renal 
function. Category A2, with albumin excretion rate of 3 – 30mg/mmol albuminuria, subjects 
with moderately impaired renal function is classified into this category.  A3 category has 
albumin excretion rate more than 30mg/mmol. A subject in this category is considered as having 
severe impaired renal function. KDIGO also allowed usage of protein reagen strip test to replace 
albumin excretion rate if it was not available. Negative or trace protein reagent strip test was put 
in A1 category, A2 as having 1+ and A3 with more than 1+ protein reagent strip test result.  
Albuminuria has been shown by various studies to be less sensitive as compared to glomerular 
filtration rate (Yasmin A and Hasniza ZH 2015). 
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GFR Category GFR (ml/min/1.73) Terms 
G1 >/= 90 Normal or High 
G2 60 – 89 Mildly decreased 
G3a 45 – 59 Mildly to moderately 
decreased 
G3b 30 – 44 Moderately to severely 
decreased 
G4 15 – 29 Severely decreased 
G5 <15 Kidney failure 
 
TABLE 1.1: Stages of CKD based on GFR (extracted from KDIGO Clinic practice  guideline for 
evaluation and management of CKD 2012) 
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Category  AER (mg/24 hrs) ACR (approximate equivalent) Terms 
(mg/mmol) (mg/g) 
A1 <30 <3 <30 Normal to mildly 
decreased 
A2 30 – 300 3-30 30 - 300 Moderately 
increased 
A3 >300 >30 >300 Severely 
increased 
 
Table 1.2: Stages of CKD based on albuminuria. (extracted from KDIGO Clinic practice  
guideline for evaluation and management of CKD 2012) 
 
 
   1.3 Multiple etiologic factors can contribute to development of chronic kidney disease.  
A study done recently in Hospital University Sains Malaysia (HUSM) by Mohamed Salman et al 
2015 in collaboration with HUSM chronic kidney disease resource center found that majority of 
subjects in their study have their cause of chronic kidney disease as secondary to diabetic 
nephropathy (44.9%). Hypertensive kidney disease was the second commonest cause in their 
cohort with 24.2% or two hundred and two subjects. Others causes of chronic kidney disease 
were obstructive uropathy (9.2%), glomerulonephritis (6.2%), toxic nephropathy 2.1%, and adult 
polycyctic kidney disease (2.2%). Miscellaneous cause was 0.8% and eighty subject (9.4%) had 
unknown cause.  
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The incidence of chronic kidney disease is increasing over the past years. A study done by Hooi 
LS et al 201 to determine the prevalence of chronic kidney disease among Malaysia adult found 
out that the prevalence of chronic kidney disease was 9.07%, with 4.16% were in CKD stage 1, 
2.05% stage 2, 2.26% stage 3, 0.24% in stage 4 and 0.36% stage 5. Hooi study finding was noted 
to be contrary with another study done by Mohamed Salman et al (2015). Mohamed Salman and 
his colleague noted increasing in trend of CKD prevalence among their study subjects. 2.1% in 
chronic kidney disease stage II, IIIa (8.7%), stage IIIb (21.9%), stage IV (28.1%) and three 
hundred thirty three subjects or 39% were CKD stage V. However it is understandable that this 
two studies to have two different findings as the 1st study done by Hooi and his colleague were 
done with normal healthy adult population whereas Mohamed Salman study used subjects 
extracted from patient admitted to hospital for the past 5 years.      
 
Multiple studies call attention to that CKD subjects having increased risk with all cause of 
mortality and all type of infections (Diego et al 2011, Naqvi SB and Collin AJ 2006, Matshusita 
et al 2012, Dalyrample LS et al 2012, James MT et al 2009, Wu MY et al 2012). However, upon 
reviewing all this articles there are a few unresolved questions. Among others were how did they 
CKD subjects get medical attention, how well they responded to our standard treatment and last 
but not least was there an indication for us to treat them in a different way empirically (of course 
with good evidence based on common etiologies among their group). 
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1.4 Pneumonia in Chronic Kidney Disease patient 
Christian and his colleagues proposed few mechanisms that can contribute to lower immunity 
among patient with CKD (2013). A chronic kidney disease directly has several consequences to 
human body. The author Christian and his colleague invented a diagram which can explain 
thoroughly this postulated theory (see figure 1.1).  
From this article and diagram, the authors suggest few mechanisms that chronic renal failure can 
lower down human immune system.  Immunosuppresion occur via uraemic accumulation of 
toxic metabolic waste, the increased turnover of the components of the alternative complement 
pathway because of impaired protein catabolism, and in cases of extensive proteinuria, the 
urinary loss of proteins with immunological functions (Christian et al 2013).  
In reality, as suggested from various studies namely, Naqvi and Collin AJ (2006), Diego et al 
2011, Antoni T et al 2013 and few others that a CKD state pose a reasonably higher risk for 
developing pneumonia. However, only some of this handful studies did highlight even the 
outcomes of pneumonia are worse than normal population. Diego et al 2011 among others 
highlighted that pneumonia in CKD population carries poorer outcome. Marin HK review a large 
US database for culture positive pneumonia also conquer with the finding. In this study, author 
found that among others, high urea and creatinine are an independent risk factor for mortality in 
pneumonia (2005).  
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Figure 1.1: Proposed mechanisms that effect immunity among CKD patient. Extracted from 
Christian K et al 2013.  
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1 OBJECTIVE 
3.1 GENERAL 
To study the clinical features, outcomes and associated factors in CKD and Non CKD patients 
affected by community acquired pneumonia 
3.2 SPECIFIC 
1. To determine main clinical features of community acquired pneumonia (CAP) that 
required hospitalization among Chronic Kidney Disease (CKD) patient, in comparison 
with non CKD patient.  
2. To determine length of hospital stay (LOS), ICU admissions, need for mechanical 
ventilation and mortality among CAP patient with CKD in comparison with patient 
without CKD.  
3. To determine the causative organism for CAP among patient with CKD in comparison 
with patient without CKD.    
 
3.3 RESEARCH QUESTION 
What are the clinical features and outcomes, clinical features and etiological agents among in 
patient chronic kidney disease (CKD) patient?  
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3.4 HYPOTHESIS 
There is significance difference in presenting clinical features of CAP such as presence of fever, 
cough, abnormal conscious level, tachypnoea, tachycardia and hypoxia between chronic kidney 
disease (CKD) group and Non chronic kidney disease group 
There is significance difference in presenting laboratory/radiological features of CAP such as 
baseline hemoglobin level, total white blood cells, albumin level, chest radiograph severity and 
total PSI score between CKD and Non CKD patient  
There is significance difference in outcomes of CAP patient such as length of hospital stay 
(LOS), mortality, requirement of mechanical ventilation, and ICU/HDW admission rate between 
CKD and Non CKD group 
There is significance different in causative organisms of CAP in CKD patient comparing to Non 
CKD patient.  
 
 
 
 
 
 
4. METHODOLOGY 
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4.1 Study Design  
Retrospective record review. 
4.2 Study approval 
This study was approved by the Research and Ethic Committee, Universiti Sains Malaysia.  
Approval reference code: USM/JEPeM/16020068 
4.3 Study period 
We conducted a retrospective review of medical records of the patient that had been admitted 
with a diagnosis of pneumonia from 2014 through May 2016 to Tertiary Teaching Hospital; 
Hospital Universiti Sains Malaysia.   
 4.4 Study population and setting 
Admission registry from admission book in all medical wards and Intensive care Unit in Hospital 
Sains Malaysia (HUSM) has been reviewed. Patient admitted with diagnosis of Community 
acquired pneumonia from January 2014 till Apr 2016 then identified.  
Medical records of the eligible subjects then traced from record office using patient’s registration 
number (RN). Only Community acquired pneumonia cases with complete clinical data, medical 
record and fulfilled all inclusion criteria without any exclusion criteria were recruited in the 
study. Potential subjects then divided into two group based on their previous known kidney 
function status. Chronic Kidney Disease group consists of subjects that fulfil definition of having 
underlying Chronic Kidney disease as has been delineated in the operational definition section. 
Subjects without Chronic kidney disease were in the other group.   
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Data then extracted from subjects medical records, online HUSM radiology system and 
microbiology lab records. Outcomes were recorded till patient has been discharge home.  
4.5 Data collection 
The subjects for this study was identified from wards registry and the intended data was 
collected from subjects medical records, online Hospital Sains Malaysia radiology system as 
well as microbiology laboratory lab registry and records.  
Subjects demographic data such as age, sex, smoking habit, race, vaccination history together 
with history of underlying co morbid and prior (pre admission) antibiotic usage was extracted 
from subject medical records.  
Subjects clinical features at admission was obtained either from admission notes from casualty 
department or referral letter notes from other hospital/clinic if the subject was a referred case 
from other hospital/clinic. Fever and cough duration history, screening saturation oxygen, vital 
sign reading mainly blood pressure and heart rate, respiratory rates and concious level by using 
Glascow Coma Scale (GCS) asessment were the clinical features variables that has been 
extracted.   
Laboratory variables obtained primarily from medical report, supported by Hospital Sains 
Malaysia online pathology or radiology report system as well as laboratory records and registry. 
Variable such as full blood count, renal profiles, arterial blood gases, glucose level, albumin 
level (corrected) and chest radiograph was obtained and documented.  Microbiology report was 
obtained from documentation in medical report and microbiology laboratory registry and reports. 
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Subjects progress in ward then reviewed and documented. Variable such as subjects antibiotic 
regime used in ward,  ICU/HDW admission, mechanical ventilation, length of hospital stay 
outcome and progress is well obtained. Cause of death was also obtained from copy of death 
certificate available in the subjects medical record. 
 
4.6 Sampling method 
Two thousand four hundred and  eighty seven community acquired pneumonia patients admitted 
was obtained from medical report reviewed. From this number; only two thousand one hundred 
and fourteen patients had their records available. This analysis was done via online medical  
records registry system. The other three hundred and seventy three patient records were not 
available due to various reason, among others was a wrong registration number entered in the 
admission registry, or human error while copying the patient registration number from admission 
registry booklet.   
Inclusion criteria was then applied to remaining subjects. Only one thousand five hundreds and 
two subjects was subsequently selected. 1502 subjects then further divided into 2 group based on 
their renal function. 1108 subjects belong to non Chronic kidney diasease (non CKD) group and 
the later 394 subjects were in the chronic kidney disease (CKD) group.   
A 199 subjects were further extracted from both group via simple random sampling method. 
Each potential subjects from study population in each group were randomly selected by using 
their registration number via a lottery method. Medical records for this 199 subjects in each 
group then been traced and its datas were extracted, examined and documented.  
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Extra precaution taken if subject do not have their previous renal function readily available; i.e 
from previous medical records or from referral notes if patient from other hospital/clinic.  No 
subjects were put into CKD group without evidence that they had underlying abnormal renal 
function for 3 months duration as per CKD definition. In view of objective of this study mainly 
to observed effect of chronic kidney disease to community acquired pneumonia patient, all 
patients with evidence of acute kidney injury and acute on chronic renal disease were excluded 
from study.  
 
4.7 INCLUSION AND EXCLUSION CRITERIAS:  
Inclusion criteria: 
1. Patient with clinical or/and radiological diagnosis of community acquired pneumonia. 
2. Age more than 18 year old (>18 years old) 
3. Baseline renal function that can fulfilled criteria of CKD or Non CKD 
 
Exclusion criteria: 
1. Patient admitted with diagnosis of hospital acquired pneumonia. Patient with hospital 
acquired infection has higher mortality and morbidity, not included in this study.  
2. Patient known in immunodeficiency state such as HIV, or on prophylaxis antibiotic post 
removal of spleen, Patient who had rheumatological or hematological disorder and/or 
currently on immunosupressive drug or long term steroid usage.  
